AbbVie Inc

AbbVie Inc (ABBV) is the lead sponsor of 200 active clinical trials listed on ClinicalTrials.gov^[5], including 59 Phase 3^[1], 48 Phase 2^[2], 54 Phase 1^[3], 6 Phase 4^[4].

Trial NCT07032597^[6] evaluates HArmonyCa Lidocaine Injectable Gel in Mid Face Volume Deficit with a target enrollment of 252 participants. Trial NCT06417775^[7] evaluates Ubrogepant in Migraine with a target enrollment of 496 participants. Trial NCT04524611^[8] evaluates Risankizumab in Crohn's Disease (CD) with a target enrollment of 527 participants.

ABBV has 3 Form 4 insider filings recorded at the SEC in the past 30 days^[9].